Skip to content

X-Zell

YC W15 · Active · Early, pain-free cancer detection.

Competitors

Adjacent

Also from W15

All of W15

About X-Zell

X-ZELL™ is a global start-up specialising in rare cell detection technology. Backed by Y Combinator and various high-profile angel investors from around the globe – among them Gmail creator Paul Buchheit – X-ZELL™ has developed a world-first platform technology capable of isolating and visualizing rare and abnormal cells such as Circulating Endothelial Cells (CEC). X-ZELL™’s platform technology is based on four core modules covering the entire spectrum from blood processing through to cell analysis and reporting – with every step performed in-house using patented and proprietary technology. By combining the wisdom of 4,000 years of pathologic research with X-ZELL™’s own, cutting-edge technology, X-ZELL™ ensures robust results and maximum clinical utility across a broad range of medical applications – from research through to medication management, companions diagnostics, relapse control and diagnostic decision-making. More information on www.x-zell.com and @XZELLInc

YC batch
W15 · Winter 2015
Status, per YC
Active
Category
Other
Team size
19
Location
Bangkok, Thailand; Düsseldorf, NRW, Germany
Checked
35m ago

YC tags: Medical Devices

X-Zell in W15: 110 companies, 24% AI

X-Zell: questions

Which YC batch was X-Zell in?

X-Zell was in Y Combinator's Winter 2015 batch (W15).

Is X-Zell still active?

Y Combinator lists X-Zell as active.

Where is X-Zell based?

X-Zell lists Bangkok, Thailand; Düsseldorf, NRW, Germany as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.